That is how he comments on here .... try to find or invent negative aspects about every piece of news possible.
And when there is nothing but positive news, then he disappears
Saying Ryoncil was a steal..... please it will cost them over 1 billion in milestone payments alone - not including never ending royalties, and the costs ( which MSB now don't have ) to develop further for other indications.
I think he may be upset something like this has not happened for CYP as they are a decade and about 40 clinical trials short.
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-343
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.038(3.64%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.757M | 3.520M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 41668 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 4094 | 3 |
View Market Depth
| Last trade - 12.32pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |